HPSE and neoplasm: Some other experimental studies have even tried to benefit from the ECM degradation capacity of heparanase-1 by engineering tumor-specific CAR (chimeric antigen receptor) expressing heparanase-1, which are capable of infiltrating stroma-rich solid tumors and of specifically killing cancer cells [53].